Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MMs been screwing around the last several weeks selling shares they don’t have and now they need to balance the books or “cover” their “short”.
Yes it is, the MMs have been selling a crap load of ghost shares in the .02-.03 range, eventually they’ll have to balance the books, so I wouldn’t be surprised to see it hit .03 before news
Not really either one, it was just a silly nonsensical response to some silly nonsense. When that movie first came out I was more like Reeves now I’m becoming Busey. I see a lot of accumulation here. It is somewhat of a mystery, maybe it’s a bunch of surfers dressed as ex presidents stealing shares. I’m going with that for now....and remember their office is near the White House
Usually happens when someone realizes they NEED shares
Reverse merger highly possible
People gotta use their heads here. David Koos came back, but he only holds half the super preferred shares....think about it, the other half of those super preferred shares just issued are waiting for someone. This company owns a serious patent for the treatment of autoimmune disease with a proprietary derivative of cannabis. Enormous potential
Big things coming.
.10 by June!
Autoimmune is a multi billion dollar industry and $RGBP has a patent for a unique cannabis element to treat it. The game has changed. Hope you have enough shares
Sounds like a cool guy. I bet he takes this cannabis patent TO THE MOON!
Autoimmune treatments have been found to have a positive effect on Covid 19 patients, I just posted the link from the NIH, that’s the National Institute of Health for anyone in Rio Linda....I think Koos will file to do a study, there’s big reasons for coming back IMO https://pubmed.ncbi.nlm.nih.gov/33332890/
Wrong answer. This stock is going to blow higher than enz&
Autoimmune and Covid 19
Evidence suggests that some medications used to treat autoimmune rheumatologic diseases might have therapeutic effect in patients with severe COVID-19
People will need therapeutics for years to come over this virus.
Riddle me this, what will happen to the share price when they file with the FDA to run a study on Covid 19 patients?
https://pubmed.ncbi.nlm.nih.gov/33332890/
The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.
Gotta take in the big picture. That’s what separates winners from losers in investing
https://www.researchandmarkets.com/reports/4828880/autoimmune-disease-therapeutics-market-by-drug
.10 by June!
$RGBP was granted a unique cannabis patent on March 4 2021, a possible game changer. Koos made a power move and regained control of the company as we can see in the filings. It only makes sense that he would now merge in his private company to create a powerhouse penny stock along the lines of enz&. Thank you for asking!
Don’t sweat the reports. I was in on cbb& Oingo was there too, it ran from .0006 to over .40, and its reports were a year or more behind. Also this company is alternative reporting so it’s not a do or die event. Have someone else verify this for you but I feel safe here. I believe that when filings do come we will be rewarded for having patience. I know that no 2 stocks are exactly alike, but this reminds me a lot of the one I mentioned furthermore look at the big humble...they are alternative reporting, have never made a dime have no service or product and look at them
Here’s another thing...just imagine the massive bump in share price this would have already had if the Sybleu onp@ deal had been done as a public company. Koos owns Sybleu and now this, and he may be planning on bringing everything under one roof
https://ih.advfn.com/stock-market/USOTC/oncology-pharma-pk-ONPH/stock-news/84445250/oncology-pharma-signs-worldwide-licensing-agreemen
Koos owns SYBLEU and receive lots of money for this patent.
Therefore yours is a completely false statement
$500,000 in stock payment on his last deal with ONPH, so sad virus, not sure where you buy such warm cups but it sounds like you must be paying half a mil.
Very possible that there’s another entity merging in here with deep pockets but that would just be icing on the cake. Enz@ ran hard, and this one is sexier, patented cannabis for medicinal treatment....the otc loves a story like this and it’s sad that sad virus doesn’t get it
It’s always better to go with the science. In this case it’s the science that says this new use of cannabis is worthy of a patent. Past is irrelevant. Anyone ever watch The Shark Tank? What does Mr Wonderful love the most? That’s right, HE LOVES LICENSING deals. Look around. CBD is everywhere, BUT to make the patent pending claim for use against autoimmune diseases, these companies are going to have to license the tech from $RGBP.
Just my thoughts based on the fact that David Koos just licensed another of his patents to a company trading at $22.00 a share.
Plus his pipeline!
Recurring revs.
Get current and this bad boy could be screaming for a dime
Here it is:
Publication number: 20210059962
Abstract: Disclosed are means, methods, and compositions of matter for stimulation of T regulatory (Treg) cells by cannabidiol. In one embodiment, administration of cannabidiol is performed in an animal suffering from autoimmunity. In situations of autoimmunity, cannabidiol induces generation of Treg cells while other agents or therapies may be used to expand such cells in vitro and/or in vivo. In some embodiments the administration of cannabidiol is performed together with agents such as low dose interleukin-2 in order to treat inflammatory conditions such as arthritis or other conditions associated with reduction in Treg cells such as pregnancy failure, type 1 diabetes, or graft versus host disease.
Type: Application
Filed: September 2, 2020
Publication date: March 4, 2021
Applicant: Regen Biopharma, Inc.
Inventors: Thomas Ichim, David Koos
https://patents.justia.com/search?q=Regen+Biopharma
Shortly after, David Koos returns to the helm at $RGBP
Follow the money train.
They are going to license this out and generate big revenue with their unique CBD application to treat autoimmune disease.
You said .02 but now that we know they have a unique patent on one of the 425 chemicals in cannabis which they can extract for use against autoimmune diseases, the sky is the limit, I see licensing deals here
CBD is already out there but this is a special patent on one of the 425 chemical entities in cannabis. So it will be a special CBD for autoimmune disease. Could be huge, I can see it going into production rather quickly with the FDA disclaimer on the label. We’re talking possible real revs, real $
Golden: https://patents.google.com/patent/US20210059962A1/en?inventor=David+Koos&sort=new
This is a game changer. If enz& can run on what it has, then a CBD patent to cure autoimmune diseases can skyrocket, all it takes is one game changer the otc loves stories like this
2 cents will be great thanks Sid!
Last time I was “warned” by him her he she it, the stock ran 20x
It’s called a mutual understanding. Or an out of court settlement. When 2 parties realize they need each other rather than attempt to hurt each other, good things can happen.
You have to have an account to log in. Anyway it’s a 2019 filing, had a whole year before Covid....by law, anything settled out of court does not have to be publicly disclosed, so I think Koos’s return to the helm speaks volumes, looks like it was settled. This is all free information easily found online by lawyers giving free advice
Sure it wasn’t settled out of court?
Looks like it never made it to court because of it.
https://pacer.login.uscourts.gov/csologin/login.jsf
Facts are what matter. Your link went nowhere, and even if we did find a Vigor Crypto Holdings LLC in Illinois it most likely means that they had plans to go public before $XALL showed them a better way. Furthermore a retraction would have to be issued by Bloomberg and Crunchbase and many other outlets if their reporting was not accurate. It would also be incumbent upon Xalles to make sure such information was retracted if it were misleading in any way.
You can tell me that it’s your opinion that the sky is green, but the rest of the world knows otherwise, therefore it’s a garbage opinion.
Maybe Bloomberg got it wrong too?
https://www.bloomberg.com/press-releases/2021-02-11/xalles-holdings-expands-cryptocurrency-strategy-with-vigor-crypto
Yeah gotta straighten out Bloomberg and Crunchbase with a nowhere link